Body Protection Compound-157 | Pentadecapeptide
DoseGear research brief
Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-157 promotes blood vessel formation, enhances collagen synthesis, modulates growth factor expression, and protects against tissue damage through localized or systemic delivery.
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Synthetic pentadecapeptide associated with gastric body-protection-compound research.
Predominantly animal tissue-injury, gastrointestinal, and wound-healing research; repair signaling remains proposed.
A cited rat muscle study followed healing for 72 days; spinal-injury research reported an outcome by day 15. These are not human recovery estimates.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Tendon/Joint healing | 250-500 mcg | 1-2x daily | SubQ near injury |
| Serious injury | 500-1000 mcg | 2x daily | SubQ near injury |
| General healing | 250-500 mcg | 1-2x daily | SubQ or IM |
| Maintenance | 250 mcg | 1x daily | SubQ |
Reference cycle
4-12 weeks depending on injury
Reference storage
Lyophilized: freezer long-term; Reconstituted: 2-8°C for 4-6 weeks
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157
Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats
BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.
